MICHAEL RAAB
CIK 1321402 · President & CEO · last filed 2026-07-17
MICHAEL RAAB is a President & CEO who has filed 148 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for ARDX, was dated Jul 17, 2026. Across all open-market trades the lifetime net is −$9.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $8.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$8.75M
4
148
-$9.19M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARDX | President & CEO | 1,721,034 | $5.08 | $8.75M | -$8.57M | 85 | 2026-07-17 |
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Director | 0 | $14.49 | $0 | -$629.0K | 28 | 2026-04-27 |
| TPST | Director | — | $0.87 | — | $0 | 6 | 2026-01-28 |
| Paratek Pharmaceuticals, Inc. (NOVC) Delisted | Director | — | — | — | $0 | 3 | 2008-03-31 |
Recent Filings
148 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-17 | ARDX | Mixed | −20,834 | -$190.3K | EDGAR |
| 2026-06-17 | ARDX | Notice (144/A) | −41,666 | -$236.7K | EDGAR |
| 2026-06-17 | ARDX | Mixed | −20,833 | -$215.7K | EDGAR |
| 2026-06-15 | ARDX | Notice (144) | −125,000 | -$711.2K | EDGAR |
| 2026-05-22 | ARDX | Sell (S) | −54,748 | -$343.1K | EDGAR |
| 2026-05-19 | ARDX | Notice (144) | −44,500 | -$277.2K | EDGAR |
| 2026-05-19 | ARDX | Mixed | −20,833 | -$241.0K | EDGAR |
| 2026-04-27 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Disp (D) | −115,857 | -$1.68M | EDGAR |
| 2026-04-17 | ARDX | Mixed | −20,834 | -$241.3K | EDGAR |
| 2026-03-18 | ARDX | Mixed | −20,833 | -$222.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.